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Introduction
Thyroid function tests (plasma hormones) can now be measured by sensitive and speci¢c assays. In the vast majority of patients, these tests, namely thyrotropin (TSH), free thyroxine (T 4 ) and free triiodothyronine (T 3 ), are adequate for the diagnosis and monitoring of thyroid disorders. 1 In some clinical situations, such as critically ill patients, these conventional tests may be misleading or may have limitations. In patients with systemic illness, a variety of abnormalities of thyroid function tests have been described. 2--5 These include low free T 3 , low T 4 and low TSH. These thyroid hormone abnormalities are seen in a variety of acute illnesses, including myocardial infarction, 6 surgery 7 bone marrow transplantations 8 and tuberculosis. 9 The degree of abnormality in thyroid function is related to the severity of the illness, and thyroid function test has been suggested to be of predictive value of survival in acutely ill patients. 10, 11 In ill patients, tests which re£ect the action of thyroid hormone at the cellular level may be helpful. 1 It has also been suggested that acutely ill patients may be hypothyroid at the cellular level. 12--14 Several tests based on the metabolic e¡ects of thyroid hormones have been described. 1 These include resting metabolic rate, relaxation time of the Achilles tendon re£ex, systolic time interval and biochemical markers such as serum cholesterol, erythrocyte carbonic anhydrase 15, 16 and erythrocyte zinc (EZn), 17--19 leucocyte alkaline phosphatase, platelet sodium and potassium ion activity, ATPase activity, 20 erythrocyte sodium pump activity, 21 serum angiotensin-converting enzyme activity (ACE), 22, 23 serum sex hormone-binding globulin (SHBG) 24 and osteocalcin. 25 Serum ACE has been reported to be higher in hyperthyroidism. 22, 23 When these patients became euthyroid, serum ACE returned to normal. Serum ACE was found to be lower in hypothyroidism, and there was a correlation between serum thyroid hormone concentration and serum ACE. 26 Serum SHBG is increased in hyperthyroidism and decreased in hypothyroidism. 24 The increase in SHBG in hyperthyroidism has been reported to cause gynaecomastia in males. 27 Erythrocyte carbonic anhydrase (ECA) has been shown to be a¡ected by the thyroid status of the individual. 15, 16, 19 As 80% of EZn is associated with this enzyme, it is also in£uenced by thyroid status. EZn and ECA are increased in hypothyroidism and decreased in hyperthyroidism. 17, 19 However, changes in EZn and ECA are slow to develop as erythrocytes have a long half-life and these re£ect integrated thyroid hormone concentrations over the previous few months, 16 in a similar way to glycated haemoglobin re£ecting glucose concentration. This fact has been used clinically to distinguish between transient hyperthyroid situations such as thyroiditis 28 or hyperthyroidism due to hyperemesis gravidarum, 29 where EZn is normal, from Grave's disease.
If ill patients are hypothyroid at the cellular level, then this will be re£ected as high EZn in newly formed (young) erythrocytes. The aim of this study was to measure EZn in young erythrocytes in hospitalized patients in order to test this hypothesis. We also measured erythrocyte creatine, which has been shown to re£ect the age of erythrocytes.
Materials and methods

Subjects
Three groups of subjects were studied: 26 control subjects, 39 critically ill patients and 19 hospitalized geriatric patients. The control subjects were attending for routine blood tests at the hospital. Any control subject, intensive care unit (ICU) or geriatric patient with known thyroid disorders or thyroid-a¡ecting medication were excluded from the study. ICU and hospitalized geriatric patients were also excluded from the study if their history included any of the following criteria: recent history of blood transfusion, a thyroid disorder, administration of thyroxine or dopamine. The study was approved by the local ethics committee and informed consent was obtained from all subjects.
Blood samples were taken into EDTA tubes for the measurement of EZn and creatine, and into vacutainer tubes without any anticoagulant for measurement of thyroid hormones.
Erythrocytes were separated according to age by centrifugation of packed erythrocytes based on the method detailed by Murphy. 30 Blood samples were centrifuged at 3000 RPM for 10 min at room temperature, and the plasma separated and stored at À701C for later analysis. Packed cells were then centrifuged at 8000 g for 30 min at room temperature. The less dense cells, which were also the youngest, were obtained by slicing the top of the erythrocyte column ('young cells'). The densest cells, which were the oldest, were obtained from the bottom ('old cells'). Each slice contained approximately 10--12% of the erythrocyte column. This method has been previously shown to separate red cells according to age. 31 Cells were lysed with distilled water and zinc concentration in the haemolysate determined by atomic absorption spectrometry. 17 The inter-assay coe⁄cient of variation (CV) of this method was 3.0% at a mean concentration of 200 mmol/L.
Erythrocyte haemoglobin was measured on a centrifugal analyser (COBAS BIO Roche Diagnostics, Basel, Switzerland) using the cyanmethamoglobin method. The di¡erentiation of the young and old erythrocytes was con¢rmed by measuring erythrocyte creatine (a marker of erythrocyte age) using diacetyl-alphanaphthol reagent, based on the method described by Li et al. 32 Haemolysates were deproteinized with barium hydroxide (0.15 mol/L) and zinc sulphate (0.17 mol/L) and the creatine content measured in the supernatant using a centrifugal analyser (Cobas Bio, Roche Diagnostics, Basel, Switzerland). Creatine dissolved in distilled water was used as the standard. The inter-assay CVof the creatine method was 3.8% at a mean concentration of 5.6 mmol/L.
Plasma freeT 3 , freeT 4 and TSH were measured using an automated chemiluminescent system (ACS Centaur, Bayer Diagnositcs). Free T 3 and free T 4 were analysed using competitive immunoassays, employing mouse and rabbit antibodies, respectively. TSH was assayed using a two-site sandwich immunoassay using sheep antibodies. The inter-assay CV for TSH was 5.31% at a mean concentration of 0.74 mU/L, that for serum free T4 was 1.95% at a mean concentration of 13.9 pmol/L, and the serum free T3 intra-assay CV was 2.35% at a mean concentration of 6.6 pmol/L.
EZn concentration was expressed in mmol/L erythrocytes using the following equation:
Zinc concentration in haemolysate ðmmol=LÞÂ10ÂMCHC ðg=dLÞ
Haemoglobin concentration in haemolysate ðg=LÞ where MCHC is the mean corpuscular haemoglobin concentration. Data were analysed using SPSS for windows statistical software. Di¡erences between groups were analysed by the Kruskal--Wallis test, followed by post hoc tests where appropriate. Po0.05 was taken as signi¢cant. Table 1 shows the age, gender and thyroid function test results in the three groups studied. The critically ill patients were older than healthy subjects. Median age for the elderly hospital groups was 85 years. There were more males in the critically ill group than in any of the other groups. The critically ill group had signi¢cantly lower TSH and freeT 3 , whereas in the elderly group free T 3 was low and TSH was not signi¢cantly di¡erent. Free T 4 concentration was not di¡erent in these groups. Low free T 3 was found in 68% and 44% of patients in the critically ill groups and elderly patients, respectively, and 18% of critically ill patients had abnormal free T 4 . Table 2 shows the creatine content of the young and old erythrocytes in the three groups. In all groups creatine content was high in the young cells. There were no di¡erences between the three groups in the erythrocyte creatine content of young or old cells. Table 3 shows the EZn content of young and old cells in the three groups. EZn was higher in the young cells of critically ill and elderly hospital patients compared with healthy subjects. EZn in the old cells was also higher in the elderly patients.
Results
Apache score in the critically ill group was not related to any of the thyroid function tests or EZn. The EZn of old cells was signi¢cantly negatively correlated with free T 3 (r ¼ À0.45, Po0.001).
Discussion
Most of the zinc present in erythrocytes is a component of metalloenzymes such as carbonic anhydrase, aldolase, alcohol dehydrogenase, glyceraldehyde dehydrogenase, malate dehydrogenase and lactate dehydrogenase. Of these, carbonic anhydase contributes to more than 80% of EZn. Two isoenzymes of carbonic anhydase are present in erythrocytes, and of these carbonic anhydase isoenzyme 1 is the predominant form. EZn therefore re£ects changes in carbonic anhydase 1 and they are highly correlated. 19 Synthesis of carbonic anhydase 1 is inhibited by thyroid hormones. In hyperthyroidism ECA and EZn are low and in hypothyroidism they are high. 17--19 When thyroid hormone status changes in an individual, ECA and EZn will change in the newly formed erythrocytes. In the erythrocytes already in circulation EZn and ECA will be normal. This is the reason for the slow return of EZn to normal when thyroid patients become euthyroid. 33 Based on these observations, we suggested that if ill patients were hypothyroid at the cellular level it would be re£ected ¢rst in the young erythrocytes. In chronically ill subjects, EZn may be abnormal in older cells as well.
In order to test this hypothesis, we separated erythrocytes by centrifugation into cells of di¡erent ages. To validate this technique, we measured erythrocyte creatine. Creatine is recognized as a marker of cell age. 34 Creatine in the top layer of cell was nearly three times higher than in the bottom layer of cells, thus con¢rming that the top layer consisted of young cells. When EZn of the young erythrocytes was compared, it was higher in critically ill as well as in elderly subjects. There may be several explanations for these observations. The control group was younger (although not statistically signi¢cantly so) than the other groups and the observed changes may be an e¡ect of the age of the individual. However, as far as we are aware, age has not been shown to a¡ect EZn.
Another possible explanation is redistribution of zinc from the extracellular to intracellular compartment as part of the in£ammatory response. 35 This is unlikely to explain the increase in EZn, as animal studies have failed to show uptake of zinc by erythrocytes during in£ammation. 35 A third possible explanation for the observed increase in EZn may be reduction in renal function. In patients with renal failure, EZn and ECA were reported to be higher. 36 In this study, iron supplementation was shown to decrease EZn but not ECA. This apparent divergence between EZn and ECA is not explained. Furthermore, the change in EZn was about 6% compared with the 15--30% change in our patients. We suggest therefore that the changes in EZn in critically ill and elderly patients are likely to be due to cellular hypothyroidism.
EZn was signi¢cantly higher in young cells in critically ill and elderly hospitalized patients. However, EZn in older cells was higher only in the elderly. This suggests that duration of illness has an e¡ect on EZn. In critically ill patients the duration is likely to be shorter than in elderly patients, although we did not record the duration of illness.
The lack of an age-matched control group and a hypothyroid group are limitations of this study. Data on the severity of the illness were also not available in all patients. Apache score in the critically ill patients was not correlated to EZn and this may be due to the relatively low number of patents in this group.
These results strongly support the hypothesis that these patients are hypothyroid at the tissue level. The signi¢cance of this is not clear. Some authors have suggested that treatment with thyroid hormones may be bene¢cial. 37 However, clinical trials using thyroid hormone in ill patients may produce con£icting results. 37 We conclude that critically ill patients and elderly hospitalized patients have high EZn, suggesting that these patients are hypothyroid at the tissue level.
